Health care issues are often so highly politicized that it’s easy to lose sight of the people behind the scenes, especially the millions of medical professionals that wake up each morning with a drive to help people. While news headlines focus on controversy, these people focus on finding answers for patients and preventing and curing disease.
On Tuesday, May 15, biopharmaceutical researchers who have devoted their careers to finding new cures and treatments left their lab coats at the office and visited California’s State Capitol in Sacramento. They came to put the politics of health care on the back (Bunsen) burner for the day and instead to spotlight the incredible innovation happening in the Golden State.
Fourteen researchers representing nine biopharmaceutical companies spent time with dozens of lawmakers and their staff to convey the commitment it takes to develop a new medicine, the rarity of successfully taking a drug to market and how today’s new era of medicine is a true game changer.
The biopharmaceutical sector is an important part of California’s economic engine, contributing nearly 900,000 well-paying jobs and pumping $261 billion into the state’s economy. The researchers who came to Sacramento are just a small part of an ecosystem that is driving the next generation of treatments and cures in the United States and around the world.
California State Senator Dr. Richard Pan welcomes biopharmaceutical researchers to the state capital in Sacramento on May 15.
Priscilla VanderVeer Priscilla VanderVeer is a deputy vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Silver Spring, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.